Indonesian Regulator BPOM Nears Agreement with China on Drug and Food Safety
What happened
The Indonesian Food and Drug Authority (BPOM) is pushing to renew its agreement with the National Medical Products Administration (NMPA), China's counterpart to BPOM. The draft of the renewed Memorandum of Understanding (MoU) is complete and is expected to be signed soon. The MoU seeks to cover various regulations, including medicines, vaccines, biological products, pharmaceutical ingredients, cosmetics, and digital regulatory technology.
From antaranews.com
Why it matters
The renewed MoU aims to establish a broader framework for international trade and regulatory cooperation between Indonesia and China. BPOM's existing status as a WHO-Listed Authority (WLA) demonstrates strong manufacturing capabilities. The agreement could pave the way for Chinese investment in Indonesian vaccine technology.
From antaranews.com
Who's involved
- IndonesiaGeopolitical state whose regulatory body is the subject of the agreement.
- Indonesian Food and Drug AuthorityIndonesian government agency responsible for product regulation and international trade.
- BeijingLocation where the parties are currently meeting to finalize the agreement.
Keep exploring
The entities involved
-
Indonesia
island country in Southeast Asia and Oceania
-
Indonesian Food and Drug Authority
Indonesian government agency
Nothing else this week.
Related events
- Indonesia confirms its membership in the RCEP bloc amid global trade shifts that are challenging the role of the World Trade Organization.
- Gorilla Technology Group Inc. announced its plans for market expansion into Indonesia and Batam.
- Minister Airlangga Hartarto announced economic growth targets and outlined a trade program in Jakarta.
- Maritime disruptions through Hormuz are impacting global supply chains, specifically affecting Chandra Asri Pacific, a major chemical conglomerate in Indonesia.